Embla Medical hf (OTCPK:OSSFF)
$ 5.1 0 (0%) Market Cap: 2.11 Bil Enterprise Value: 2.57 Bil PE Ratio: 31.48 PB Ratio: 2.87 GF Score: 79/100

Q2 2024 Embla Medical hf Earnings Call Transcript

Jul 23, 2024 / 07:00AM GMT
Release Date Price: $4.25 (-0.47%)
Sveinn Solvason
Embla Medical hf - President & CEO

Good morning, and welcome to the Embla Medical conference call where we will review second quarter results for 2024. My name is Sveinn Solvason, President and CEO of Embla Medical, joining me today is our Chief Financial Officer, Arna Sveinsdottir; Embla Medical's new Head of Investor Relations, Klaus Sindahl is also with us today joining remotely from Copenhagen.

Today I will discuss the financial performance and progress we've made during the second half of 2024, the presentation should take roughly 10 to 15 minutes after which there will be an opportunity to ask questions during a Q&A session.

And if you turn to the next slide, please. We delivered our highest ever quarterly sales in the second quarter. Sales amounted to $217 million and organic growth was 6% in local currency, growth was 9% when including acquisitions. Sales growth for the second quarter was driven by the Prosthetics & Neuro Orthotics and strong contribution from our Patient Care segment. In our Bracing & Supports business delivered more modest

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot